Enhanced blood pressure buffering role of the brain nitrergic system in renin transgenic rats

Brain Research

Volumn 842, Issue 2, 1999, Pages 384-391

  Lon S ^a   Szczepanska Sadowska E ^a   Paczwa, P ^a   Ganten, D ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Hypertension; L NNA; Nitric oxide; Vasopressin

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN VENTRICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; FEMORAL ARTERY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL;

EID: 0345062218     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01857-0     Document Type: Article

References (36)

1. Boulanger C.M., Caputo L., Levy B.I. Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension. 26:1995;752-757.
2. Budzikowski A.W., Paczwa P., Szczepańska-Sadowska E. Central V1 AVP receptors are involved in cardiovascular adaptation to hypovolemia in WKY but not in SHR rats. Am. J. Physiol. 271:1996;H1057-H1064.
3. Cabrera C.L., Bealer S.L., Bohr D.F. Central depressor action of nitric oxide is deficient in genetic hypertension. Am. J. Hypertens. 9:1996;237-241.
4. Calka J., Block C.H. Relationship of vasopressin with NADPH-diaphorase in the hypothalamo-neurohypophysial system. Brain Res. Bull. 32:1993;207-210.
5. Cameron V., Espiner E.A., Nicholls M.G., Donald R.A., MacFarlane M.R. Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage. Endocrinology. 116:1985;1460-1465.
6. Chardonnes D., Lang U., Capponi A.M., Vallotton M.B. Comparison of the effects of angiotensin II and vasopressin on cytosolic free calcium concentration, protein kinase C activity, and prostacyclin production in cultured rat aortic and mesenteric smooth muscle cells. J. Cardiovasc. Pharmacol. 14:1989;S39-S44.
7. Dampney R.A.L. Functional organization of central nervous pathways regulating the cardiovascular system. Physiol. Rev. 74:1994;323-364.
8. Dun N.J., Dun S.L., Förstermann U. Nitric oxide synthase immunoreactivity in rat pontine medullary neurons. Neuroscience. 59:1994;429-445.
9. G-nitro-L-arginine) on blood pressure and plasma renin. Clin. Exp. Hypertens. 15:1993;819-832.
10. Ganten D., Lindpaintner K., Ganten U., Peters J., Zimmermann F., Bader M., Mullins J. Transgenic rats: new animal model in hypertension research. Hypertension. 17:1991;843-855.
11. Gerstberger R., Fahrenholz F. Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney. Eur. J. Pharmacol. 167:1989;105-116.
12. Harada S., Tokunaga S., Momohara M., Masaki H., Tagawa T., Imaizumi T., Takeshita A. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic activity in rabbits. Circ. Res. 72:1993;511-516.
13. Horn T., Smith P.M., McLaughlin E., Bauce L., Marks G.S., Pittman Q.J., Ferguson A.V. Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am. J. Physiol. 266:1994;R306-R313.
14. Janiak P., Kasson B.G., Brody M.J. Central vasopressin raises arterial pressure by sympathetic activation and vasopressin release. Hypertension. 13:1989;935-940.
15. Moriguchi A., Brosnihan K.B., Kumagai H., Ganten D., Ferrario C.M. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. Am. J. Physiol. 266:1994;R1273-R1279.
16. Moriguchi A., Ferrario C.M., Brosnihan K.B., Ganten D., Morris M. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-gene. Am. J. Physiol. 267:1994;R786-R791.
17. Nakamoto H., Ferrario C.M., Fuller C.M., Robaczewski D.L., Winicow E., Dean R.H. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 25:1995;796-802.
18. Donnel M.E.O., Owen N.H. Regulation of ion pumps and carriers in vascular smooth muscle. Physiol. Rev. 74:1994;683-721.
19. Okada K., Ishikawa S., Saito T. Enhancement of intracellular sodium by vasopressin in spontaneously hypertensive rats. Hypertension. 22:1993;300-305.
20. G-nitro-L-arginine. Brain Res. 748:1997;51-61.
21. Paczwa P., Budzikowski A.S., Szczepańska-Sadowska E. Role of endogenous centrally released NO in cardiovascular adaptation to hypovolemia in WKY and SHR rats. Am. J. Physiol. 272:1997;H2282-H2288.
22. Rascher W., Lang R.E., Unger T., Ganten D., Gross F. Vasopressin in brain of spontaneously hypertensive rats. Am. J. Physiol. 242:1982;H496-H499.
23. Rudichenko V.M., Beierwaltes W.H. Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J. Vasc. Res. 32:1995;100-105.
24. Sanchez F., Alonso J.R., Arevalo R., Blanco E., Aijon J., Vazquez R. Coexistence of NADPH-diaphorase with vasopressin and oxytocin in the hypothalamic magnocellular neurosecretory nuclei of the rat. Cell Tissue Res. 276:1994;31-34.
25. Senanayake P.D., Moriguchi A., Kumagai H., Ganten D., Ferrario C.M., Brosnihan K.B. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides. 15:1994;919-926.
26. Simon-Oppermann C., Gray D.A., Szczepańska-Sadowska E., Simon E. Vasopressin in blood and third ventricle CSF of dogs in chronic experiments. Am. J. Physiol. 245:1983;R541-R545.
27. Sladek C.D., Devine M.A., Felten S.J., Aravich P.F., Blair M.L. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat. Brain Res. 45:1988;39-46.
28. Stȩpniakowski K., Budzikowski A., Łoń S., Szczepańska-Sadowska E. Central cardiovascular effects of AVP and ANP in normotensive and spontaneously hypertensive rats. J. Auton. Nerv. Sys. 47:1994;33-43.
29. Styś T., Styś A., Paczwa P., Szczepańska-Sadowska E., Lipkowski A.W. Decreased hypotensive responsiveness to nitric oxide donor S-nitroso-N-acetyl-DL-penicillamine (SNAP) in spontaneously hypertensive (SHR) rats. J. Physiol. Pharmacol. 49:1998;37-49.
30. G-nitro-L-arginine on pressor action of arginine vasopressin in normotensive (WKY) and spontaneously hypertensive (SHR) rats. J. Physiol. Pharmacol. 45:1994;231-240.
31. Sun M.-K., Guyenet P.G. Effects of vasopressin and other neuropeptides on rostral medullary sympathoexcitatory neurons "in vitro" Brain Res. 492:1989;261-270.
32. Szczepańska-Sadowska E., Paczwa P., Łoń S., Ganten U., Ganten D. Enhancement of the central pressor effect of vasopressin by blockade of brain nitric oxide synthase in renin transgenic rats. J. Mol. Med. 76(B 29):1998;108. abstr.
33. Szczepańska-Sadowska E., Paczwa P., Łoń S., Ganten D. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats. J. Hypertens. 16:1998;1505-1514.
34. S.R. Vincent, Localization of nitric oxide neurons in the central nervous system, in: S.R. Vincent (Ed.), Nitric Oxide in the Nervous System, Academic Press, London, 1995, pp. 83-102.
35. Yamori Y., Lovenberg W. Spontaneously hypertensive rats. Hypertension. 9:1987;I13-114. Supl. 1.
36. Zanzinger J., Czachurski J., Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am. J. Physiol. 268:1995;R958-R962.